The Strong Families Trial: Randomised Controlled Trial Of A Family Strengthening Program To Prevent Unhealthy Weight Gain Among 5- To 11-year Old Children From At Risk Families
Funder
National Health and Medical Research Council
Funding Amount
$1,338,625.00
Summary
The study will test the effectiveness of an integrated package of parenting and lifestyle interventions for parents or carers from socially disadvantaged areas in reducing the risk of obesity among their 5-11 year-old children. It will provide scientific evidence of the additive effectiveness of a mixed parenting program when combined with a standard lifestyle intervention to prevent unhealthy weight gain and improving the family environment among mostly migrant populations
Effectiveness Of An Early Intervention Trial To Prevent Obesity - Phase 2: Follow-up And Cost Effectiveness Analysis
Funder
National Health and Medical Research Council
Funding Amount
$435,690.00
Summary
Internationally, Healthy Beginnings Trial (HBT) is the first randomised controlled trial to test the effectiveness of an early childhood obesity intervention in 0-2 year olds. It is a home-based early intervention designed to improve family and behavioural risk factors for childhood obesity. We seek funding for conducting the follow-up to ages 3.5 and 5 years, and a cost-effectiveness analysis. This will permit the appropriate assessment of this internationally novel trial, which has already att ....Internationally, Healthy Beginnings Trial (HBT) is the first randomised controlled trial to test the effectiveness of an early childhood obesity intervention in 0-2 year olds. It is a home-based early intervention designed to improve family and behavioural risk factors for childhood obesity. We seek funding for conducting the follow-up to ages 3.5 and 5 years, and a cost-effectiveness analysis. This will permit the appropriate assessment of this internationally novel trial, which has already attracted a significant investment.Read moreRead less
The Central Australian Heart Protection Study: A Randomised Trial Of Nurse-Led, Family Based Secondary Prevention Of Acute Coronary Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$1,923,630.00
Summary
Despite the high burden of cardiovascular diseases among Indigenous Australians, few intervention trials have sought to evaluate novel approaches to reducing differential outcomes in this vulnerable group. The Central Australian Heart Protection Study seeks to test the effectiveness of a nurse-led, family based education and assessment program in reducing the incidence of poor outcomes in indigenous and non-indigenous patient’s following an Acute Coronary Syndrome (ACS).
Defining The Molecular And Functional Features Of Protective HIV-specific T Cells
Funder
National Health and Medical Research Council
Funding Amount
$591,966.00
Summary
Human immunodeficiency virus (HIV) directly attacks our immune system, impairing our natural defense against infection and disease. HIV has claimed over 39 million lives worldwide since its discovery, and no vaccine is currently available. Despite this, there are some individuals with a particular genetic advantage able to control HIV infection who never get sick. Understanding how these individuals control HIV so efficiently may lead to novel treatments or potential vaccines against HIV.
Intraductal Carcinoma Of The Prostate: Indicator Of Aggressive Disease.
Funder
National Health and Medical Research Council
Funding Amount
$884,377.00
Summary
This proposal addresses the need to improve personalised treatment decisions for men with high risk familial prostate cancer as they have a very aggressive disease progression with a very poor clinical outcome. We will perform biological and pre-clinical studies to improve the clinical diagnosis, prognosis and treatment options for men with germline mutations in BRCA2 or BRCA1 genes who develop prostate cancer.
Statistical Issues In The Analysis Of Host-viral Genetic Associations
Funder
National Health and Medical Research Council
Funding Amount
$252,849.00
Summary
Viruses such as HIV or Hepatitis B or C may escape detection, and hence control, by the human host immune system through strategic mutations. This project aims to develop statistical methodologies which will facilitate determination of the locations of these strategic mutations and assess the relative impact of different human-host genetic characteristics. Application of the results should benefit the design of tailored vaccines and studies of drug resistance.
Volitional And Non-volitional Control Of Human Balance: Normal Physiology And Changes With Ageing
Funder
National Health and Medical Research Council
Funding Amount
$383,066.00
Summary
How does the brain control balance when we stand? Our research shows that two very distinct processes operate to produce distinct postural, perceptual and cardiovascular outcomes. These experiments investigate the neurophysiology that coordinates these systems and what happens with age. The results will fundamentally change views on balance control. Balance problems are common in neurological disorders and old age. Knowing how balance works will improve diagnosis, treatment and rehabilitation.
Cell Trafficking In A Stem Cell Model For Hereditary Spastic Paraplegia
Funder
National Health and Medical Research Council
Funding Amount
$524,082.00
Summary
Hereditary Spastic Paraplegia (HSP) is a genetic disease passed down in affected families. It is a slowly progressing lower limb paralysis that gradually restricts daily activities until the sufferer is confined to bed. There are no cures. This project investigates patientsÍ stem cells to study how HSP genes cause disease. We will use these stem cells to discover new potential drug therapies.
Stimulation Of Human Immunodeficiency Virus Type 1 (HIV-1) Specific Cytolytic Effector Function Using Allogeneic Cell Immunotherapy
Funder
National Health and Medical Research Council
Funding Amount
$377,648.00
Summary
A preventative HIV vaccine is not currently available. Stimulation of the bodies own immune cells (T-cells) may be associated with better protection against the virus, and we have recently discovered that T-cells already present in humans are frequently stimulated by foreign (allogeneic) cells. Therefore we aim to determine if “vaccination” with allogeneic cells could stimulate a HIV specific immune response in humans. These results could have important implications for HIV vaccine design.
Group A Streptococcal Human Challenge Study: Accelerating Vaccine Development
Funder
National Health and Medical Research Council
Funding Amount
$2,018,741.00
Summary
Infection with group A streptococcus (GAS) is a major cause of morbidity and mortality worldwide, including in the Aboriginal population of Australia. Concerted efforts for vaccine development have been hampered by the absence of a suitable animal model. To address this critical knowledge gap we propose to develop a controlled human infection model of GAS infection. This model will provide a direct pathway for the future appraisal of novel GAS vaccines.